| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ERBB4 OR11G2 HLA-DRB1 HLA-DRB3 HLA-DRB5 OR52L1 OR5H15 GRIN1 ADGRV1 OR2H1 S1PR3 BDKRB2 LEPR CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 ROS1 FCRL5 OR6T1 IL17RD OR5H1 OR2H2 | 1.42e-07 | 1353 | 130 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.64e-05 | 49 | 130 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR11G2 OR52L1 OR5H15 ADGRV1 OR2H1 S1PR3 BDKRB2 CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 OR6T1 OR5H1 OR2H2 | 1.72e-05 | 884 | 130 | 18 | GO:0004930 |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 2.68e-05 | 27 | 130 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | ABC-type vitamin B12 transporter activity | 4.21e-05 | 2 | 130 | 2 | GO:0015420 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 4.28e-05 | 11 | 130 | 3 | GO:0032395 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR11G2 OR52L1 OR5H15 OR2H1 OR2M4 OR51E1 OR2AT4 OR51Q1 OR6T1 OR5H1 OR2H2 | 1.21e-04 | 431 | 130 | 11 | GO:0004984 |
| GeneOntologyMolecularFunction | MHC protein complex binding | 1.44e-04 | 41 | 130 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | peptide binding | HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GRIN1 CCKAR TPP1 GPR149 TAP2 | 2.40e-04 | 318 | 130 | 9 | GO:0042277 |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 4.34e-04 | 23 | 130 | 3 | GO:0015245 | |
| GeneOntologyMolecularFunction | hormone binding | 5.69e-04 | 103 | 130 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.84e-04 | 28 | 130 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | 2-acylglycerol O-acyltransferase activity | 1.15e-03 | 8 | 130 | 2 | GO:0003846 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.32e-03 | 73 | 130 | 4 | GO:0170055 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 2.59e-06 | 16 | 130 | 4 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 2.59e-06 | 16 | 130 | 4 | GO:0002503 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 8.30e-06 | 21 | 130 | 4 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 8.30e-06 | 21 | 130 | 4 | GO:0002501 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.27e-05 | 48 | 130 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.23e-05 | 58 | 130 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.72e-05 | 32 | 130 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 7.59e-05 | 36 | 130 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR11G2 OR52L1 OR5H15 OR2H1 OR2M4 OR51E1 OR2AT4 OR51Q1 OR6T1 OR5H1 OR2H2 | 9.33e-05 | 432 | 130 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 9.42e-05 | 38 | 130 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell antigen processing and presentation | 1.18e-04 | 3 | 130 | 2 | GO:0002469 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.19e-04 | 76 | 130 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR11G2 OR52L1 OR5H15 OR2H1 OR2M4 OR51E1 OR2AT4 OR51Q1 OR6T1 OR5H1 OR2H2 | 1.78e-04 | 465 | 130 | 11 | GO:0007608 |
| GeneOntologyCellularComponent | MHC class II protein complex | 3.29e-06 | 17 | 131 | 4 | GO:0042613 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PIGN MBTPS1 LMF1 DPY19L1 SAMD8 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GRIN1 SEC31B GGCX LPIN1 GDPD5 THADA NFE2L1 LPIN2 ABCD4 LPGAT1 TMEM39A TAP2 DGAT1 | 1.70e-05 | 1293 | 131 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PIGN MBTPS1 LMF1 DPY19L1 SAMD8 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GRIN1 SEC31B GGCX LPIN1 GDPD5 THADA NFE2L1 LPIN2 ABCD4 LPGAT1 TMEM39A TAP2 DGAT1 | 1.83e-05 | 1299 | 131 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | MHC protein complex | 1.98e-05 | 26 | 131 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PIGN MBTPS1 LMF1 DPY19L1 SAMD8 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GRIN1 SEC31B GGCX LPIN1 GDPD5 THADA NFE2L1 LPIN2 ABCD4 LPGAT1 TMEM39A TAP2 DGAT1 | 2.53e-05 | 1327 | 131 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | inner dynein arm | 2.79e-05 | 10 | 131 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 5.07e-05 | 64 | 131 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.46e-05 | 210 | 131 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 6.63e-05 | 35 | 131 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.31e-04 | 48 | 131 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | autolysosome membrane | 2.32e-04 | 4 | 131 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.93e-04 | 431 | 131 | 10 | GO:0031253 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.00e-04 | 25 | 131 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 5.75e-04 | 6 | 131 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 5.75e-04 | 6 | 131 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 5.75e-04 | 6 | 131 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | cleavage furrow | 5.83e-04 | 61 | 131 | 4 | GO:0032154 | |
| GeneOntologyCellularComponent | ruffle membrane | 5.96e-04 | 108 | 131 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.48e-04 | 110 | 131 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.06e-03 | 8 | 131 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.54e-03 | 79 | 131 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | cell division site | 1.61e-03 | 80 | 131 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | Golgi membrane | MBTPS1 MGAT4B SAMD8 ASAH2 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HUWE1 DSEL IL17RD DOP1B | 1.94e-03 | 721 | 131 | 12 | GO:0000139 |
| GeneOntologyCellularComponent | hemidesmosome | 2.07e-03 | 11 | 131 | 2 | GO:0030056 | |
| Domain | MHC_II_b_N | 1.54e-07 | 8 | 130 | 4 | PD000328 | |
| Domain | MHC_II_b_N | 2.75e-07 | 9 | 130 | 4 | IPR000353 | |
| Domain | MHC_II_beta | 2.75e-07 | 9 | 130 | 4 | SM00921 | |
| Domain | MHC_II_beta | 2.75e-07 | 9 | 130 | 4 | PF00969 | |
| Domain | MHC_II_a/b_N | 2.13e-06 | 14 | 130 | 4 | IPR014745 | |
| Domain | - | 2.13e-06 | 14 | 130 | 4 | 3.10.320.10 | |
| Domain | GPCR_Rhodpsn_7TM | OR11G2 OR52L1 OR5H15 OR2H1 S1PR3 BDKRB2 CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 OR6T1 OR5H1 OR2H2 | 4.11e-06 | 670 | 130 | 17 | IPR017452 |
| Domain | 7tm_1 | OR11G2 OR52L1 OR5H15 OR2H1 S1PR3 BDKRB2 CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 OR6T1 OR5H1 OR2H2 | 4.72e-06 | 677 | 130 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR11G2 OR52L1 OR5H15 OR2H1 S1PR3 BDKRB2 CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 OR6T1 OR5H1 OR2H2 | 5.51e-06 | 685 | 130 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR11G2 OR52L1 OR5H15 OR2H1 S1PR3 BDKRB2 CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 OR6T1 OR5H1 OR2H2 | 6.18e-06 | 691 | 130 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | OR11G2 OR52L1 OR5H15 OR2H1 S1PR3 BDKRB2 CCKAR OR2M4 OR51E1 ADRB3 OR2AT4 OR51Q1 GPR149 RXFP2 OR6T1 OR5H1 OR2H2 | 6.30e-06 | 692 | 130 | 17 | IPR000276 |
| Domain | PH_dom-spectrin-type | 2.68e-05 | 9 | 130 | 3 | IPR001605 | |
| Domain | Olfact_rcpt | OR11G2 OR52L1 OR5H15 OR2H1 OR2M4 OR51E1 OR2AT4 OR51Q1 OR6T1 OR5H1 OR2H2 | 9.65e-05 | 393 | 130 | 11 | IPR000725 |
| Domain | MHC_I/II-like_Ag-recog | 1.38e-04 | 38 | 130 | 4 | IPR011162 | |
| Domain | - | 1.41e-04 | 15 | 130 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 1.41e-04 | 15 | 130 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.41e-04 | 15 | 130 | 3 | IPR023394 | |
| Domain | Lipin_N | 1.44e-04 | 3 | 130 | 2 | IPR007651 | |
| Domain | Lipin_mid | 1.44e-04 | 3 | 130 | 2 | IPR031703 | |
| Domain | Lipin_N | 1.44e-04 | 3 | 130 | 2 | PF04571 | |
| Domain | Lipin_mid | 1.44e-04 | 3 | 130 | 2 | PF16876 | |
| Domain | SEC7 | 1.73e-04 | 16 | 130 | 3 | PS50190 | |
| Domain | Sec7 | 1.73e-04 | 16 | 130 | 3 | SM00222 | |
| Domain | Sec7_dom | 1.73e-04 | 16 | 130 | 3 | IPR000904 | |
| Domain | C1-set | 5.41e-04 | 54 | 130 | 4 | PF07654 | |
| Domain | IGc1 | 6.22e-04 | 56 | 130 | 4 | SM00407 | |
| Domain | LNS2 | 7.08e-04 | 6 | 130 | 2 | IPR013209 | |
| Domain | LNS2 | 7.08e-04 | 6 | 130 | 2 | SM00775 | |
| Domain | LNS2 | 7.08e-04 | 6 | 130 | 2 | PF08235 | |
| Domain | LNS2/PITP | 7.08e-04 | 6 | 130 | 2 | IPR031315 | |
| Domain | Ig/MHC_CS | 7.11e-04 | 58 | 130 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 7.11e-04 | 58 | 130 | 4 | IPR003597 | |
| Domain | IG_MHC | 8.08e-04 | 60 | 130 | 4 | PS00290 | |
| Domain | ABC_TM1F | 9.50e-04 | 28 | 130 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 9.50e-04 | 28 | 130 | 3 | IPR011527 | |
| Domain | - | 1.77e-03 | 74 | 130 | 4 | 3.40.50.410 | |
| Domain | Phosphodiest/P_Trfase | 2.09e-03 | 10 | 130 | 2 | IPR002591 | |
| Domain | Phosphodiest | 2.09e-03 | 10 | 130 | 2 | PF01663 | |
| Domain | - | 2.54e-03 | 11 | 130 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 2.54e-03 | 11 | 130 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 2.54e-03 | 11 | 130 | 2 | PF00082 | |
| Domain | VWFA | 2.58e-03 | 82 | 130 | 4 | PS50234 | |
| Domain | VWA | 2.81e-03 | 84 | 130 | 4 | SM00327 | |
| Domain | ABC_transporter_CS | 3.10e-03 | 42 | 130 | 3 | IPR017871 | |
| Domain | AAA | 3.36e-03 | 144 | 130 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 3.36e-03 | 144 | 130 | 5 | IPR003593 | |
| Domain | Dynein_HC_stalk | 4.14e-03 | 14 | 130 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.14e-03 | 14 | 130 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.14e-03 | 14 | 130 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.14e-03 | 14 | 130 | 2 | IPR011704 | |
| Domain | MT | 4.14e-03 | 14 | 130 | 2 | PF12777 | |
| Domain | AAA_5 | 4.14e-03 | 14 | 130 | 2 | PF07728 | |
| Domain | ABC_tran | 4.53e-03 | 48 | 130 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.53e-03 | 48 | 130 | 3 | PS50893 | |
| Domain | DHC_fam | 4.76e-03 | 15 | 130 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.76e-03 | 15 | 130 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.76e-03 | 15 | 130 | 2 | IPR004273 | |
| Domain | ABC_TRANSPORTER_1 | 4.81e-03 | 49 | 130 | 3 | PS00211 | |
| Domain | VWF_A | 5.07e-03 | 99 | 130 | 4 | IPR002035 | |
| Domain | ABC_transporter-like | 5.09e-03 | 50 | 130 | 3 | IPR003439 | |
| Domain | bZIP_2 | 6.11e-03 | 17 | 130 | 2 | PF07716 | |
| Domain | - | MXRA5 COL20A1 PSG11 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 LEPR ROS1 FCRL5 CD96 | 6.64e-03 | 663 | 130 | 11 | 2.60.40.10 |
| Domain | LRR_8 | 6.93e-03 | 171 | 130 | 5 | PF13855 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 1.71e-08 | 13 | 97 | 5 | M18928 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 2.65e-08 | 14 | 97 | 5 | M22023 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 6.70e-07 | 11 | 97 | 4 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 6.70e-07 | 11 | 97 | 4 | M22048 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 2.00e-06 | 14 | 97 | 4 | M10765 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 2.00e-06 | 14 | 97 | 4 | M1473 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 2.71e-06 | 15 | 97 | 4 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 2.71e-06 | 15 | 97 | 4 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 2.71e-06 | 15 | 97 | 4 | M7298 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 8.56e-06 | 41 | 97 | 5 | M13519 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 9.84e-06 | 72 | 97 | 6 | M3126 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.09e-05 | 43 | 97 | 5 | M12617 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 1.40e-05 | 22 | 97 | 4 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 1.40e-05 | 22 | 97 | 4 | M1467 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 1.69e-05 | 23 | 97 | 4 | M6705 | |
| Pathway | REACTOME_PD_1_SIGNALING | 3.80e-05 | 28 | 97 | 4 | M18810 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 4.38e-05 | 29 | 97 | 4 | M6910 | |
| Pathway | KEGG_ASTHMA | 5.03e-05 | 30 | 97 | 4 | M13950 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 6.64e-05 | 12 | 97 | 3 | MM15447 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 1.09e-04 | 14 | 97 | 3 | M619 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.17e-04 | 37 | 97 | 4 | M18615 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR11G2 OR52L1 OR5H15 OR2H1 OR2M4 OR51E1 OR2AT4 OR51Q1 OR6T1 OR5H1 OR2H2 | 1.35e-04 | 417 | 97 | 11 | M4072 |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.44e-04 | 39 | 97 | 4 | M16523 | |
| Pathway | WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY | 2.39e-04 | 18 | 97 | 3 | M42546 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 3.25e-04 | 48 | 97 | 4 | M615 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 3.29e-04 | 87 | 97 | 5 | M6856 | |
| Pathway | WP_ETHER_LIPID_BIOSYNTHESIS | 3.31e-04 | 20 | 97 | 3 | M46451 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 3.47e-04 | 88 | 97 | 5 | M16004 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 4.43e-04 | 52 | 97 | 4 | M13103 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 5.06e-04 | 23 | 97 | 3 | MM15575 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 5.70e-04 | 98 | 97 | 5 | M965 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 9.62e-04 | 7 | 97 | 2 | MM15703 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.03e-03 | 65 | 97 | 4 | M39682 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 1.28e-03 | 8 | 97 | 2 | M45025 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.36e-03 | 70 | 97 | 4 | M12294 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 1.42e-03 | 389 | 97 | 9 | M14091 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 1.98e-10 | 4 | 132 | 4 | 3476943 | |
| Pubmed | 1.98e-10 | 4 | 132 | 4 | 26740600 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 1.98e-10 | 4 | 132 | 4 | 12144077 | |
| Pubmed | 1.98e-10 | 4 | 132 | 4 | 18520346 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 17910142 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 9.88e-10 | 5 | 132 | 4 | 1970352 | |
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 7645219 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 12392858 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 9.88e-10 | 5 | 132 | 4 | 17182961 | |
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 11782380 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 23152536 | ||
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 9.88e-10 | 5 | 132 | 4 | 17507489 | |
| Pubmed | 9.88e-10 | 5 | 132 | 4 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 9.88e-10 | 5 | 132 | 4 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 9.88e-10 | 5 | 132 | 4 | 12144632 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 9.88e-10 | 5 | 132 | 4 | 12202216 | |
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 17431094 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 17153701 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 18305173 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 15902698 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 2.96e-09 | 6 | 132 | 4 | 19235017 | |
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 11082517 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 15896200 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 11997714 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 2.96e-09 | 6 | 132 | 4 | 14508706 | |
| Pubmed | 6.88e-09 | 7 | 132 | 4 | 18569076 | ||
| Pubmed | 6.88e-09 | 7 | 132 | 4 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 6.88e-09 | 7 | 132 | 4 | 12230470 | |
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 6.88e-09 | 7 | 132 | 4 | 18846964 | |
| Pubmed | 6.88e-09 | 7 | 132 | 4 | 20307907 | ||
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 19223392 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 1.37e-08 | 8 | 132 | 4 | 16405603 | |
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 12296785 | ||
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 17106278 | ||
| Pubmed | 1.37e-08 | 8 | 132 | 4 | 23729440 | ||
| Pubmed | 2.46e-08 | 9 | 132 | 4 | 24505475 | ||
| Pubmed | 2.46e-08 | 9 | 132 | 4 | 23170932 | ||
| Pubmed | 4.09e-08 | 10 | 132 | 4 | 15784911 | ||
| Pubmed | 4.09e-08 | 10 | 132 | 4 | 12956878 | ||
| Pubmed | 4.09e-08 | 10 | 132 | 4 | 8450224 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 20371654 | ||
| Pubmed | Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. | 5.34e-08 | 3 | 132 | 3 | 16815190 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 10609818 | ||
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 5.34e-08 | 3 | 132 | 3 | 9500545 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 5.34e-08 | 3 | 132 | 3 | 12121280 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 19811438 | ||
| Pubmed | Diversity associated with the second expressed HLA-DRB locus in the human population. | 5.34e-08 | 3 | 132 | 3 | 9162096 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 3099214 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 2471740 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 22531795 | ||
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 5.34e-08 | 3 | 132 | 3 | 15730527 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 20193583 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 8016840 | ||
| Pubmed | Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. | 5.34e-08 | 3 | 132 | 3 | 8775462 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 16441501 | ||
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 5.34e-08 | 3 | 132 | 3 | 12358860 | |
| Pubmed | Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. | 5.34e-08 | 3 | 132 | 3 | 8462990 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 3466180 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 1428007 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 7652736 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 5.34e-08 | 3 | 132 | 3 | 2023919 | |
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 5.34e-08 | 3 | 132 | 3 | 2511168 | |
| Pubmed | A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. | 5.34e-08 | 3 | 132 | 3 | 12008082 | |
| Pubmed | 6.41e-08 | 11 | 132 | 4 | 21085635 | ||
| Pubmed | 6.41e-08 | 11 | 132 | 4 | 22808111 | ||
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 1.93e-07 | 14 | 132 | 4 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 1.93e-07 | 14 | 132 | 4 | 1869305 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 19136718 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 14677183 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 19922436 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 17002906 | ||
| Pubmed | Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype. | 2.13e-07 | 4 | 132 | 3 | 3020127 | |
| Pubmed | HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. | 2.13e-07 | 4 | 132 | 3 | 15795121 | |
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 2.62e-07 | 15 | 132 | 4 | 22860026 | |
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 9079699 | ||
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 8376762 | ||
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 8168144 | ||
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 7602119 | ||
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 1967269 | ||
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 3489470 | ||
| Pubmed | 2.62e-07 | 15 | 132 | 4 | 10729169 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 3.48e-07 | 16 | 132 | 4 | 2846691 | |
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 3.48e-07 | 16 | 132 | 4 | 2543930 | |
| Pubmed | 3.48e-07 | 16 | 132 | 4 | 17959659 | ||
| Pubmed | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. | 3.48e-07 | 16 | 132 | 4 | 9223324 | |
| Pubmed | 3.48e-07 | 16 | 132 | 4 | 1978941 | ||
| Pubmed | 4.54e-07 | 17 | 132 | 4 | 25240755 | ||
| Pubmed | HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. | 5.31e-07 | 5 | 132 | 3 | 17559577 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 15908298 | ||
| Pubmed | The role of HLA molecules in susceptibility to chronic rheumatic heart disease. | 5.31e-07 | 5 | 132 | 3 | 16426242 | |
| Pubmed | EFA6 activates Arf6 and participates in its targeting to the Flemming body during cytokinesis. | 5.31e-07 | 5 | 132 | 3 | 23603394 | |
| Pubmed | HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. | 5.31e-07 | 5 | 132 | 3 | 17763415 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 16916662 | ||
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 5.82e-07 | 18 | 132 | 4 | 19620308 | |
| Pubmed | 5.82e-07 | 18 | 132 | 4 | 11118314 | ||
| Pubmed | 5.82e-07 | 18 | 132 | 4 | 10661406 | ||
| Pubmed | 9.16e-07 | 20 | 132 | 4 | 12427289 | ||
| Cytoband | 6p21.3 | 9.07e-05 | 250 | 132 | 6 | 6p21.3 | |
| Cytoband | 11p15.4 | 2.95e-04 | 200 | 132 | 5 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 5.18e-04 | 54 | 132 | 3 | chr3q11 | |
| GeneFamily | C1-set domain containing | 6.59e-05 | 42 | 94 | 4 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 7.93e-05 | 44 | 94 | 4 | 588 | |
| GeneFamily | Lipins | 8.00e-05 | 3 | 94 | 2 | 1043 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HAUS6 ATRX FOSB AOAH RALGAPB HECTD4 CLDND1 FRYL HUWE1 BIRC6 ERBIN LPIN1 KANSL1 MAP4K1 TPP1 LPIN2 LPGAT1 TAP2 CD96 TOP2B RASGRP2 SMAD7 PSD4 | 1.13e-06 | 1492 | 130 | 23 | M40023 |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 3.24e-06 | 21 | 130 | 4 | M41167 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | DPY19L1 FOSB HLA-DRB1 SLC22A23 ARHGAP5 IFITM3 SERPINB2 ENPP5 ARHGAP28 TMEM39A IL1B | 2.07e-05 | 412 | 119 | 11 | GSM538260_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | PIGN MBTPS1 ATRX DPY19L1 VEZT VEPH1 RALGAPB PEX1 SSBP1 HUWE1 BIRC6 KANSL1 ROS1 TOP2B DOP1B | 2.84e-05 | 774 | 119 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.SI, CD45+ MHCII+ CD11c-lo CD11b+, Small Intestine, avg-5 | 2.97e-05 | 64 | 119 | 5 | GSM854280_100 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | PDE3A FOSB HLA-DRB1 ITGB1 S1PR3 NR2F1 GGT7 LPIN1 OR51E1 IFITM3 CPNE4 TAP2 PAQR7 RASGRP2 SMAD7 | 7.39e-05 | 842 | 119 | 15 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | DPY19L1 FOSB HLA-DRB1 SLC22A23 ARHGAP5 IFITM3 SERPINB2 ENPP5 ARHGAP28 IL1B | 8.12e-05 | 397 | 119 | 10 | GSM605827_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-2 | DPY19L1 FOSB HLA-DRB1 SLC22A23 ARHGAP5 IFITM3 SERPINB2 ARHGAP28 TMEM39A IL1B | 9.96e-05 | 407 | 119 | 10 | GSM538258_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | PIGN MBTPS1 PDE3A PSD ATRX DPY19L1 SSBP1 HUWE1 S1PR3 LEPR KANSL1 ARHGAP28 TMEM26 TOP2B | 1.08e-04 | 772 | 119 | 14 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 181 | 130 | 7 | 154d5e586cab25155c6d06dfe6ae01203b88e0fb | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 182 | 130 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 182 | 130 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-06 | 188 | 130 | 7 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-06 | 188 | 130 | 7 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.62e-06 | 193 | 130 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 158 | 130 | 6 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 158 | 130 | 6 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 158 | 130 | 6 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-06 | 159 | 130 | 6 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-06 | 159 | 130 | 6 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.01e-05 | 168 | 130 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 176 | 130 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.36e-05 | 177 | 130 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 178 | 130 | 6 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-05 | 179 | 130 | 6 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-05 | 180 | 130 | 6 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-05 | 181 | 130 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-05 | 181 | 130 | 6 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 182 | 130 | 6 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 182 | 130 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 184 | 130 | 6 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 187 | 130 | 6 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 187 | 130 | 6 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 187 | 130 | 6 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 190 | 130 | 6 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 190 | 130 | 6 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 190 | 130 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.02e-05 | 190 | 130 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-05 | 192 | 130 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-05 | 192 | 130 | 6 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-05 | 192 | 130 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5-_Mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 195 | 130 | 6 | fe3f978820a63c26a537d97e69f7999dd60bb0ea | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.41e-05 | 196 | 130 | 6 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.41e-05 | 196 | 130 | 6 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.48e-05 | 197 | 130 | 6 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.48e-05 | 197 | 130 | 6 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 198 | 130 | 6 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-05 | 198 | 130 | 6 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 199 | 130 | 6 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | 15-Airway-Immune|Airway / Age, Tissue, Lineage and Cell class | 2.63e-05 | 199 | 130 | 6 | a737061703af06cfa1acdf95f77b9d42b3cd7c33 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 77 | 130 | 4 | 9a29879348b32b6c2302820f75fd55efba39aae8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 77 | 130 | 4 | c5262a0d2040b2c580601e5a8d1ec626a0c7b560 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 77 | 130 | 4 | 3763b55e5ce44b844da661e9024c9f2c847ea26f | |
| ToppCell | BL-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 160 | 130 | 5 | 3f737451d5713deed20061aa72a9ef77a9a2bc06 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 161 | 130 | 5 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.10e-04 | 161 | 130 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 161 | 130 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 161 | 130 | 5 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 165 | 130 | 5 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-04 | 170 | 130 | 5 | b62f7184e78e9672ea88e361654f604f9df2dc5f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 170 | 130 | 5 | 31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-04 | 170 | 130 | 5 | 00fe77bca9c28762212c498f9c49e14cb1492cca | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 170 | 130 | 5 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 170 | 130 | 5 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 171 | 130 | 5 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 171 | 130 | 5 | 2c7d73f1386ddd172839734c68ed3859a90f80f8 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 171 | 130 | 5 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 172 | 130 | 5 | 0bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.50e-04 | 172 | 130 | 5 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 174 | 130 | 5 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 174 | 130 | 5 | a0a059bb2a64d7011e206db2ebcdf3eb655a925a | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 174 | 130 | 5 | 7cd6f9103133f8d7b90f9ff4b3b0b078cf554542 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 175 | 130 | 5 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 1.63e-04 | 175 | 130 | 5 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 175 | 130 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 176 | 130 | 5 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 176 | 130 | 5 | a23d484aff5ad094333b2feae9106ca219514711 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 176 | 130 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.67e-04 | 176 | 130 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-04 | 177 | 130 | 5 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-04 | 177 | 130 | 5 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-04 | 178 | 130 | 5 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.81e-04 | 179 | 130 | 5 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 179 | 130 | 5 | ae9d90a4eac2cfa545a764df84914c5801544278 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 179 | 130 | 5 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 179 | 130 | 5 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 179 | 130 | 5 | 5bf191bdc0c32bce83ab5c38f0616e209e420e55 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 180 | 130 | 5 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.85e-04 | 180 | 130 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 180 | 130 | 5 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 181 | 130 | 5 | 51836cdc66e42f04ed6a3c167cd6a3a67428c9f7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 181 | 130 | 5 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 181 | 130 | 5 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 1.95e-04 | 182 | 130 | 5 | cd0b9f0a25147ec3bc1e32d698511d1c3b33891f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 182 | 130 | 5 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.09e-07 | 11 | 128 | 4 | DOID:0080822 (is_implicated_in) | |
| Disease | pancreatitis (implicated_via_orthology) | 6.57e-06 | 9 | 128 | 3 | DOID:4989 (implicated_via_orthology) | |
| Disease | forced expiratory volume, body mass index | 1.28e-05 | 11 | 128 | 3 | EFO_0004314, EFO_0004340 | |
| Disease | islet cell tumor (is_marker_for) | 1.87e-05 | 2 | 128 | 2 | DOID:1799 (is_marker_for) | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 1.87e-05 | 2 | 128 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | myoglobinuria (implicated_via_orthology) | 5.59e-05 | 3 | 128 | 2 | DOID:0080108 (implicated_via_orthology) | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 5.59e-05 | 3 | 128 | 2 | DOID:639 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 6.20e-05 | 18 | 128 | 3 | DOID:0080208 (is_implicated_in) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.65e-04 | 63 | 128 | 4 | DOID:3083 (is_implicated_in) | |
| Disease | Allergic Reaction | 1.65e-04 | 63 | 128 | 4 | C1527304 | |
| Disease | Hypersensitivity | 1.75e-04 | 64 | 128 | 4 | C0020517 | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0801672 | |
| Disease | body mass index, vital capacity | 2.77e-04 | 6 | 128 | 2 | EFO_0004312, EFO_0004340 | |
| Disease | extranodal nasal NK/T cell lymphoma | 2.77e-04 | 6 | 128 | 2 | MONDO_0019472 | |
| Disease | multiple sclerosis (is_implicated_in) | 2.92e-04 | 73 | 128 | 4 | DOID:2377 (is_implicated_in) | |
| Disease | cervix uteri carcinoma in situ (is_implicated_in) | 3.87e-04 | 7 | 128 | 2 | DOID:8991 (is_implicated_in) | |
| Disease | pancreatic cancer (biomarker_via_orthology) | 3.87e-04 | 7 | 128 | 2 | DOID:1793 (biomarker_via_orthology) | |
| Disease | bullous pemphigoid | 4.32e-04 | 34 | 128 | 3 | EFO_0007187 | |
| Disease | interleukin-21 measurement | 5.14e-04 | 8 | 128 | 2 | EFO_0801724 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 5.56e-04 | 37 | 128 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | Graves' disease (is_implicated_in) | 6.50e-04 | 39 | 128 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0007790 | |
| Disease | 5-acetylamino-6-formylamino-3-methyluracil measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0800950 | |
| Disease | central nervous system non-hodgkin lymphoma | 6.59e-04 | 9 | 128 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0801686 | |
| Disease | obesity (is_implicated_in) | 6.75e-04 | 91 | 128 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | DIP2B ABCC1 ASAH2 SLC22A23 AOAH HECTD4 BIRC6 OR2M4 KANSL1 HOOK1 NFE2L1 FANCI LPIN2 PUS1 SMAD7 | 7.56e-04 | 1347 | 128 | 15 | EFO_0005192 |
| Disease | pulmonary tuberculosis (is_implicated_in) | 8.09e-04 | 42 | 128 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | CCL19 measurement | 8.21e-04 | 10 | 128 | 2 | EFO_0009415 | |
| Disease | Cryptorchidism | 8.21e-04 | 10 | 128 | 2 | C0010417 | |
| Disease | Adenoid Cystic Carcinoma | 9.60e-04 | 100 | 128 | 4 | C0010606 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 9.90e-04 | 45 | 128 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 9.90e-04 | 45 | 128 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | pancreatic cancer (is_marker_for) | 9.97e-04 | 101 | 128 | 4 | DOID:1793 (is_marker_for) | |
| Disease | cocaine use measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0010553 | |
| Disease | gallbladder neoplasm | 1.00e-03 | 11 | 128 | 2 | C0016978 | |
| Disease | 5-acetylamino-6-amino-3-methyluracil measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0800951 | |
| Disease | vascular dementia (is_marker_for) | 1.00e-03 | 11 | 128 | 2 | DOID:8725 (is_marker_for) | |
| Disease | Malignant neoplasm of gallbladder | 1.00e-03 | 11 | 128 | 2 | C0153452 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 1.20e-03 | 12 | 128 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | N-acetylputrescine measurement | 1.20e-03 | 12 | 128 | 2 | EFO_0800127 | |
| Disease | Trigeminal Neuralgia | 1.20e-03 | 12 | 128 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 1.20e-03 | 12 | 128 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 1.20e-03 | 12 | 128 | 2 | C0393786 | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.20e-03 | 12 | 128 | 2 | EFO_0009273 | |
| Disease | non-alcoholic steatohepatitis | 1.20e-03 | 12 | 128 | 2 | EFO_1001249 | |
| Disease | Reactive Hyperemia | 1.41e-03 | 13 | 128 | 2 | C0178824 | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 1.41e-03 | 13 | 128 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | ventricular enlargement measurement | 1.41e-03 | 13 | 128 | 2 | EFO_0010570 | |
| Disease | uveitis (is_implicated_in) | 1.41e-03 | 13 | 128 | 2 | DOID:13141 (is_implicated_in) | |
| Disease | Leishmaniasis, Visceral | 1.41e-03 | 13 | 128 | 2 | C0023290 | |
| Disease | pleurisy (implicated_via_orthology) | 1.41e-03 | 13 | 128 | 2 | DOID:10247 (implicated_via_orthology) | |
| Disease | Venous Engorgement | 1.41e-03 | 13 | 128 | 2 | C0042484 | |
| Disease | Paranoid Schizophrenia | 1.41e-03 | 13 | 128 | 2 | C0036349 | |
| Disease | Active Hyperemia | 1.41e-03 | 13 | 128 | 2 | C0333233 | |
| Disease | Hyperemia | 1.41e-03 | 13 | 128 | 2 | C0020452 | |
| Disease | parental longevity | 1.45e-03 | 494 | 128 | 8 | EFO_0007796 | |
| Disease | complement C4 measurement | 1.51e-03 | 52 | 128 | 3 | EFO_0004984 | |
| Disease | C-C motif chemokine 19 measurement | 1.64e-03 | 14 | 128 | 2 | EFO_0008047 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.64e-03 | 195 | 128 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | lymphocyte measurement | 1.72e-03 | 117 | 128 | 4 | EFO_0803546 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.77e-03 | 55 | 128 | 3 | EFO_0004623, HP_0002140 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.87e-03 | 56 | 128 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 1.89e-03 | 15 | 128 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.89e-03 | 15 | 128 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 1.92e-03 | 517 | 128 | 8 | EFO_0010554 | |
| Disease | response to vaccine | 2.00e-03 | 122 | 128 | 4 | EFO_0004645 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 2.07e-03 | 58 | 128 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | fibrinogen measurement, factor VII measurement | 2.07e-03 | 58 | 128 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | lung small cell carcinoma (is_marker_for) | 2.15e-03 | 16 | 128 | 2 | DOID:5409 (is_marker_for) | |
| Disease | Urticaria | 2.15e-03 | 16 | 128 | 2 | C0042109 | |
| Disease | basophil measurement | 2.28e-03 | 60 | 128 | 3 | EFO_0803539 | |
| Disease | Inborn Errors of Metabolism | 2.43e-03 | 17 | 128 | 2 | C0025521 | |
| Disease | anti-anoctamin 2 antibody measurement | 2.43e-03 | 17 | 128 | 2 | EFO_0010150 | |
| Disease | Astrocytosis | 2.43e-03 | 17 | 128 | 2 | C3887640 | |
| Disease | Lipidemias | 2.43e-03 | 17 | 128 | 2 | C1706412 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 2.43e-03 | 17 | 128 | 2 | EFO_0010559, GO_0035456 | |
| Disease | Gliosis | 2.43e-03 | 17 | 128 | 2 | C0017639 | |
| Disease | Hyperlipidemia | 2.43e-03 | 17 | 128 | 2 | C0020473 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 2.50e-03 | 62 | 128 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 2.51e-03 | 215 | 128 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | ABCC1 HLA-DRB1 THADA KANSL1 HOOK1 LPIN2 PUS1 LPGAT1 ENPP5 SLC35E3 | 2.58e-03 | 799 | 128 | 10 | EFO_0010701 |
| Disease | Alzheimer's disease (is_implicated_in) | 2.66e-03 | 132 | 128 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | late-onset myasthenia gravis | 2.73e-03 | 18 | 128 | 2 | EFO_1001490 | |
| Disease | rheumatoid arthritis, COVID-19 | 2.74e-03 | 64 | 128 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 3.04e-03 | 19 | 128 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | hepatitis B virus infection | 3.04e-03 | 19 | 128 | 2 | EFO_0004197 | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.12e-03 | 67 | 128 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Cardiomyopathies, Primary | 3.39e-03 | 69 | 128 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.39e-03 | 69 | 128 | 3 | C0036529 | |
| Disease | Malignant Glioma | 3.53e-03 | 70 | 128 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.53e-03 | 70 | 128 | 3 | C0259783 | |
| Disease | Henoch-Schoenlein purpura | 4.07e-03 | 22 | 128 | 2 | EFO_1000965 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 4.07e-03 | 22 | 128 | 2 | EFO_0021881 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLNIQSWPPNMTDFS | 401 | Q15303 | |
| VMFISDNESFNPSLW | 436 | Q96RT1 | |
| PSLIWEVFTNMLLNV | 216 | P30411 | |
| SFWECPNIVNIDLSM | 151 | P0C7U0 | |
| LFELLFNWSMSLPCN | 3521 | Q9NR09 | |
| KWFNNSAASLTMPTL | 261 | Q8TDL5 | |
| SAPNNMTFLKSTWFL | 686 | Q9H7T0 | |
| TIANFTFSAWVMPNA | 1351 | Q8WXG9 | |
| PNDVMQQSWHTFLLL | 201 | P32238 | |
| QTWQCILSALMASLP | 2151 | Q96M86 | |
| LFPSWSSQNALMFLT | 31 | O14678 | |
| MTSATLNQPLWLNLN | 451 | Q6P1W5 | |
| AIAWTPRLQTMTNVF | 61 | P13945 | |
| LFFTQLQVGLIQQWM | 286 | O75907 | |
| NPMSDKLTFSVIWTL | 456 | Q8IYB7 | |
| TNTICWNPMEAFIFT | 241 | Q9NV06 | |
| QRVEMNFISLFWPSL | 311 | P22894 | |
| SPFDLEQQWQDLMSI | 306 | Q14494 | |
| WSELFVLNAAQCSMP | 256 | P10589 | |
| MNLQPIFWIGLISSV | 1 | P05556 | |
| AWISSTVTPKMLNNF | 71 | A6NDH6 | |
| SPEWITASQMSLNSF | 271 | P28039 | |
| LEPSSPQFVQMLSWT | 996 | Q9NVI1 | |
| WYISTSQAENMPVFL | 236 | P01584 | |
| FTTSCVPQMLVNLWG | 71 | O95918 | |
| QAVFLPMAAFLAWLS | 171 | Q86WK9 | |
| RSVPWLMTLNLSNNS | 71 | Q9HBL6 | |
| EMWQSYLILTAPLSQ | 5311 | Q9NU22 | |
| MAPWLQLCSVFFTVN | 1 | Q8NFM7 | |
| EMTLSNLWIFLIQSF | 336 | Q92604 | |
| LIQNGDWTFQTLVML | 176 | Q30154 | |
| TLLMKQAWPQNSSSC | 61 | Q92567 | |
| PALNELLSVWNMGFS | 756 | Q14703 | |
| FISLFNSVSQWVQLM | 196 | Q7LDG7 | |
| QQPSEDWMILEFSQL | 286 | Q9UQ53 | |
| SPIFTQFLDCIWQLM | 396 | Q96EF0 | |
| DHVVWSLFNTLFMNP | 56 | Q01628 | |
| LISWFAIHPVSMNNS | 296 | Q9NR71 | |
| LWPIMVSELIQTFTQ | 2091 | Q9Y3R5 | |
| LSPNFQITAMWSKDS | 241 | Q96RD9 | |
| ILLNSQMLDFSWPNR | 506 | Q9UJ14 | |
| MVWENQTFNSIFILL | 1 | Q96R27 | |
| PKMLAIFWFNSTTIQ | 81 | Q8TCB6 | |
| TLTTLPTVMQLLWFN | 76 | Q8NH59 | |
| MEQLNTWNFPIFDLV | 686 | Q14432 | |
| SFWNVQDLLNSAMPR | 391 | Q9UJA9 | |
| AFNTLQALMLDFPDW | 596 | O94915 | |
| QSTTEPTNLMATIFW | 1991 | O94915 | |
| PTNLMATIFWIAASL | 1996 | O94915 | |
| WIQIMFLFQQSLFPE | 616 | Q14D04 | |
| FMLPWQFAQFVLLTQ | 251 | Q2PZI1 | |
| PMELENNLFLWLSTV | 1226 | Q9P265 | |
| PTSLHFQSMLKSQWQ | 676 | Q7Z3B3 | |
| WTTAAPLLLAMQAFQ | 516 | Q14693 | |
| NFNLTFSWPMSKVNI | 726 | P48357 | |
| FSWPMSKVNIVQSLS | 731 | P48357 | |
| PASMLNWTTLQRLNA | 296 | Q8WTR4 | |
| SLLMAPESNAAQIWT | 1671 | Q9Y4D8 | |
| SEWISQMATLPQASN | 1511 | Q7Z6Z7 | |
| AWISSTVTPKMLNNF | 71 | A6NKK0 | |
| QLWASLTPASTQQEM | 171 | A8MVW0 | |
| DLQWLVQPTLISSMA | 66 | P53539 | |
| SVLSVTIFMFLQWPN | 81 | Q86SP6 | |
| LMAASLYNNTVPELW | 4061 | Q9P2D7 | |
| LIQNGDWTFQTLVML | 176 | P79483 | |
| TALVVCPLNTALNWM | 1621 | P46100 | |
| LLQSTYATPVDMWSV | 186 | P11802 | |
| FALWQMTAEDFQPLL | 916 | Q9P218 | |
| TEVVMNNLSPAWKSF | 196 | Q96A23 | |
| DPSVAQEMNTFISLW | 106 | Q6TDU7 | |
| TEACTENPNWALLMF | 631 | Q6TDU7 | |
| TMLWLALSSAAAAQP | 261 | A0PJE2 | |
| LIQNGDWTFQTLVML | 176 | P01911 | |
| LIQNGDWTFQTLVML | 176 | P13762 | |
| PSTNKTMLWNSFQIS | 746 | Q7Z4H7 | |
| VSLMLNTWPVISAFA | 141 | Q6UW01 | |
| DSLMIWLQTFNTASP | 16 | Q9UJC3 | |
| NFWNLPTTAQVMIEA | 26 | Q9UQ72 | |
| QWFIVLAVLNSAMNP | 281 | Q99500 | |
| WTQFVNVTFQMEPTI | 661 | Q8IZU8 | |
| PTMENQVQTLTSYLW | 81 | Q9H7H0 | |
| DIWNSLSSVFTEMQP | 321 | Q9BUN1 | |
| FYSWLQQSTTTMLPL | 466 | O43933 | |
| SQFLEWVNLEPQSMV | 576 | Q13474 | |
| FIWFLIPIVNISQMS | 191 | Q8NGC1 | |
| MNPQTNATLAASAWL | 141 | A6NND4 | |
| QNLFLSPWSISSTMA | 26 | P05120 | |
| FTTSCVPQMLVNLWG | 71 | Q9GZK4 | |
| MLLSNSSWRLSQPSF | 16 | Q8NGH7 | |
| DLATYINMIWSAPLQ | 436 | P33527 | |
| MLFPSRTTWVYSINN | 536 | Q92918 | |
| SQTLSPTWNQMLLFN | 866 | Q2WGJ9 | |
| NLFVTWQQRSTPATM | 2816 | Q5T011 | |
| SPIWQNMCGLLSIFT | 221 | Q6YHU6 | |
| TWSMLQFPLDLAVQN | 216 | Q6ZUK4 | |
| AIQQMLFPNQEFSWL | 391 | Q99624 | |
| VFLFQAPSLEQMQSW | 846 | A5PKW4 | |
| PDFNYILNMSLWSLT | 1141 | Q02880 | |
| WALDVLSPNLISTSM | 91 | O75792 | |
| SMTPFISALQSTDWL | 96 | Q96LT4 | |
| WSDTMNIFCPQDTII | 421 | Q7Z3H4 | |
| SMAQWLSTLPIHNFS | 386 | Q9Y606 | |
| SIFPESLRWLMATQQ | 361 | A1A5C7 | |
| LFMQSLWPQLTDGAT | 11 | Q9BQS7 | |
| NFSVNMWNAITPLRT | 431 | Q9NQW5 | |
| LFQAPTAKEMSSWIA | 871 | Q8NDX1 | |
| MTSWIVIFFLPVNSA | 671 | Q8WXD0 | |
| NVQRTPLMDNWYSLS | 506 | Q8N695 | |
| DTTLMSNWLPLNANV | 256 | Q03519 | |
| MNPENWTQVTSFVLL | 1 | Q8NGN1 | |
| INLMTADNLSICFWP | 1401 | Q13017 | |
| IFIWDLNNLNVPMTL | 146 | Q9NQW1 | |
| GSAAFITNSLMNPIW | 136 | Q9BSK2 | |
| VSAPLQFMASALFIW | 221 | Q9NY35 | |
| MQQPWTGFTVQISFV | 386 | O15105 | |
| FQRTSWVQPLLMDLS | 496 | P38435 | |
| AQSDNLTIWCMALSP | 346 | P40200 | |
| WINAFVMLTTQLLPS | 326 | Q9NV64 | |
| SLWNISTVMAPNLFF | 531 | Q9P2N2 | |
| KNPVTIFSLATNEMW | 51 | Q04837 | |
| NISELSAMIPQFDWL | 301 | P78562 | |
| WIAVNVTPSVMSFQL | 1101 | P08922 | |
| FTSMPQLSEQWRQQL | 446 | Q8IYU4 | |
| PLMNQIISWATLASS | 681 | O95427 | |
| QTWFRFLHMLSNPVD | 281 | Q86X10 | |
| QFPWLIMNEEQTALF | 146 | O60290 | |
| ETLISWLQAQMLNPQ | 81 | O43592 | |
| TPNIWDLSMLFAFIS | 141 | Q9HBM0 | |
| WVTAFLNHPQLSAMI | 196 | Q9H489 | |
| LLFQTQSPEEMQGWI | 876 | Q9NYI0 | |
| FPNMSLTLVHFVVTW | 41 | Q7Z769 | |
| IFGSQTLPNSNLWTM | 1176 | Q6EMB2 | |
| QEPFLQWLMLLSNES | 301 | O14773 | |
| GNLSFLNWLTMVPSL | 306 | Q96S06 | |
| WALAAPMILSLQVFQ | 521 | Q92539 | |
| FQLPQWSISLNMTDE | 311 | Q9NR99 | |
| LDSFMQPFQSTLWLL | 551 | Q05586 |